白血病, 骨髄増殖性疾患, 骨髄異形成症候群発症の分子メカニズム
北村 俊雄, 渡辺 直子, 米野由希子 et al. · 臨床血液 · 2009
Cited by 0 works. doi:10.11406/rinketsu.50.174
Authors
References
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
- A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
- Plat-E: an efficient and stable system for transient packaging of retroviruses
- Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
- Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow
- PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
- JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
- Acute leukemia with promyelocytic features in PML/RARα transgenic mice